tradingkey.logo

BioNexus Gene Lab Corp

BGLC
4.150USD
+0.050+1.22%
收盘 12/24, 13:00美东报价延迟15分钟
7.46M总市值
亏损市盈率 TTM

BioNexus Gene Lab Corp

4.150
+0.050+1.22%

关于 BioNexus Gene Lab Corp 公司

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

BioNexus Gene Lab Corp简介

公司代码BGLC
公司名称BioNexus Gene Lab Corp
上市日期Mar 11, 2020
CEOTan (Lee Su-Leng)
员工数量30
证券类型Ordinary Share
年结日Mar 11
公司地址10-2 Tower B, Vertical Business Suite
城市KUALA LUMPUR
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Malaysia
邮编59200
电话13072416898
网址https://www.bionexusgenelab.com/
公司代码BGLC
上市日期Mar 11, 2020
CEOTan (Lee Su-Leng)

BioNexus Gene Lab Corp公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-0.08%
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月6日 周六
更新时间: 12月6日 周六
持股股东
股东类型
持股股东
持股股东
占比
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
其他
63.04%
持股股东
持股股东
占比
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
其他
63.04%
股东类型
持股股东
占比
Corporation
24.00%
Individual Investor
12.39%
Investment Advisor
0.94%
其他
62.67%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
14
22.28K
1.52%
--
2025Q3
14
22.28K
2.00%
+12.71K
2025Q2
13
9.56K
1.47%
-6.24K
2025Q1
13
15.80K
1.33%
-8.09K
2024Q4
12
17.81K
1.26%
+4.78K
2024Q3
9
13.03K
0.67%
+6.46K
2024Q2
7
6.57K
0.88%
-3.53K
2024Q1
7
10.10K
0.59%
-313.00
2023Q4
6
10.42K
1.15%
-9.94K
2023Q3
5
20.36K
0.00%
+20.36K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Liew (Choong-Chin)
166.67K
9.28%
--
--
Feb 27, 2025
Lai (Soo Kow(kenny))
125.00K
6.96%
--
--
Feb 27, 2025
UBS Financial Services, Inc.
9.56K
0.53%
+9.56K
--
Jun 30, 2025
Low (Jook Yuen)
1.26K
0.07%
--
--
Feb 27, 2025
Blackstone Alternative Investment Advisors LLC
3.00
0%
--
--
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Apr 03, 2025
Merger
10→1
公告日期
类型
比率
Apr 03, 2025
Merger
10→1

常见问题

BioNexus Gene Lab Corp的前五大股东是谁?

BioNexus Gene Lab Corp 的前五大股东如下:
Liew (Choong-Chin)持有股份:166.67K,占总股份比例:9.28%。
Lai (Soo Kow(kenny))持有股份:125.00K,占总股份比例:6.96%。
UBS Financial Services, Inc.持有股份:9.56K,占总股份比例:0.53%。
Low (Jook Yuen)持有股份:1.26K,占总股份比例:0.07%。
Blackstone Alternative Investment Advisors LLC持有股份:3.00,占总股份比例:0.00%。

BioNexus Gene Lab Corp的前三大股东类型是什么?

BioNexus Gene Lab Corp 的前三大股东类型分别是:
Fidelion Diagnostics Pte Ltd
ARC Group Ltd
Liew (Choong-Chin)

有多少机构持有BioNexus Gene Lab Corp(BGLC)的股份?

截至2025Q4,共有14家机构持有BioNexus Gene Lab Corp的股份,合计持有的股份价值约为22.28K,占公司总股份的1.52%。与2025Q3相比,机构持股有所增加,增幅为-0.48%。

哪个业务部门对BioNexus Gene Lab Corp的收入贡献最大?

在--,--业务部门对BioNexus Gene Lab Corp的收入贡献最大,创收--,占总收入的--%。
KeyAI